title: Response to: 'Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years' by Yamamoto et al.
authors.affiliation: Allergy and Immunology Division, Department of Rheumatology, Massachusetts General Hospital, Boston, Massachusetts, USA.
authors.forename: John H
authors.initials: JH
authors.lastname: Stone
authors.affiliation: Department of Rheumatology, Massachusetts General Hospital, Boston, Massachusetts, USA.
authors.forename: Mollie N
authors.initials: MN
authors.lastname: Carruthers
authors.affiliation: Department of Gastroenterology & Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
authors.forename: Mark D
authors.initials: MD
authors.lastname: Topazian
authors.affiliation: Department of Rheumatology, Emory University School of Medicine, Atlanta, Georgia, USA.
authors.forename: Arezou
authors.initials: A
authors.lastname: Khosroshahi
authors.affiliation: Department of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
authors.forename: Thomas E
authors.initials: TE
authors.lastname: Witzig
authors.affiliation: Rheumatology Unit, Massachusetts General Hospital, Boston, Massachusetts, USA.
authors.forename: Zachary S
authors.initials: ZS
authors.lastname: Wallace
authors.affiliation: Department of Gastroenterology & Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
authors.forename: Phillip A
authors.initials: PA
authors.lastname: Hart
authors.affiliation: Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA.
authors.forename: Vikram
authors.initials: V
authors.lastname: Deshpande
authors.affiliation: Department of Pathology, Mayo Clinic, Rochester, Minnesota, USA.
authors.forename: Thomas C
authors.initials: TC
authors.lastname: Smyrk
authors.affiliation: Department of Gastroenterology & Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
authors.forename: Suresh
authors.initials: S
authors.lastname: Chari
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology*; D008297:Male
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D007074:Immunoglobulin G
keywords: Rehabilitation; Rheumatoid Arthritis; Treatment